TN-401 is a gene therapy commercialized by Tenaya Therapeutics, with a leading P...
CTX-131 is a gene-modified cell therapy commercialized by CRISPR Therapeutics, w...
Lemzoparlimab is a monoclonal antibody commercialized by I-Mab, with a leading P...
(Clesacostat tromethamine + Ervogastat) is a small molecule commercialized by Pf...
Imlunestrant tosylate is a small molecule commercialized by Eli Lilly and Co, wi...
ADI-001 is a gene-modified cell therapy commercialized by Adicet Bio, with a lea...
Rapcabtagene autoleucel is a gene-modified cell therapy commercialized by Novart...
Public health experts are anticipating a changing discourse following RFK Jr’s a...
AIM ImmunoTech has secured a patent from the Netherlands Patent Office for Ampli...
RLYB-116 is a fusion protein commercialized by Rallybio, with a leading Phase I ...
ORIC-944 is a small molecule commercialized by ORIC Pharmaceuticals, with a lead...
Rhenium (186Re) Obisbemeda is a small molecule commercialized by Plus Therapeuti...
The results from the Phase III trial found the LDL-C treatment to be well tolera...
The EMA has validated Chiesi Global Rare Diseases and Protalix’s submission to u...
The respiratory syncytial virus (RSV) prophylaxis market across the eight major ...
An improved price discount and new evidence from Santhera has changed NICE’s tun...
